Top 10 Pre-Market Gainers From Thursday
June 02, 2016 at 09:42 AM EDT
Repros Therapeutics (NASDAQ: RPRX) was trading up 19.53% after reporting success of its Enclomiphene drug to treat secondary ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.